Cargando…
Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study
BACKGROUND: The soluble suppression of tumorigenicity 2 receptor (sST2) binds to interleukin-33 (IL-33) and blocks IL-33 and ST2 binding, suggesting that sST2 acts as a “decoy” receptor for IL-33 and is involved in the malignant progression of breast cancer. This paper aimed to investigate the diffe...
Autores principales: | Chen, Chong, Li, Jianhua, Rossi, Lorenzo, Sun, Pei, She, Tiantian, He, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493791/ https://www.ncbi.nlm.nih.gov/pubmed/37701118 http://dx.doi.org/10.21037/tcr-23-792 |
Ejemplares similares
-
Serum soluble ST2 is associated with ER-positive breast cancer
por: Lu, Da-peng, et al.
Publicado: (2014) -
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022) -
Soluble ST2 in serum predicts the prognosis of idiopathic pulmonary fibrosis: a retrospective study
por: Yu, Yan-Zhe, et al.
Publicado: (2022) -
Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma
por: Li, Jian-Jun, et al.
Publicado: (2013) -
Prognostic value of serum soluble ST2 in stable coronary artery disease: a prospective observational study
por: Kim, Hack-Lyoung, et al.
Publicado: (2021)